PolyPeptide Group AG
PolyPeptide Group AG is a Swiss CDMO company based in Baar (Zug). It holds no Swissmedic authorisations for human medicines of its own and is listed here as a CDMO.
Key facts
| Sector | CDMO |
|---|---|
| City | Baar |
| Canton | Zug |
| Authorisation holder | No |
| Medicines | Not available |
| Founded | 1952 |
| Employees | 1001-5000 |
| Parent group | Not available |
| Activity | contract development and manufacturing of therapeutic peptides |
| Website | polypeptide.com |
Medicines authorised in Switzerland
No medicine authorisation
PolyPeptide Group AG is not recorded as an authorisation holder for human medicines with Swissmedic. That is normal for device manufacturers, contract manufacturers, wholesalers, laboratories and consultancies.
Contract development and manufacturing of active ingredients, peptides and finished products.
Frequently asked questions
How many medicines does PolyPeptide Group AG have authorised in Switzerland?
PolyPeptide Group AG holds no Swissmedic authorisations for human medicines (as of 1 September 2026). The company is listed here as a CDMO business.
Where is PolyPeptide Group AG based?
The Swiss location recorded for PolyPeptide Group AG is Baar, Zug.
Is PolyPeptide Group AG a Swissmedic authorisation holder?
No. PolyPeptide Group AG does not appear as an authorisation holder in the Swissmedic list. To reach the Swiss market, a foreign manufacturer needs an authorisation holder domiciled or represented in Switzerland.